Evaluation of Commercial Thyme Essential Oil Samples According to European Pharmacopoeia 10.0 Criteria


Creative Commons License

Kavi N., Bayri İ. Ş., Şentürk T. B., Barak T. H.

The 12th Conference on Medicinal and Aromatic Plants of Southeast European Countries, İzmir, Türkiye, 17 Ekim 2024, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: İzmir
  • Basıldığı Ülke: Türkiye
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Essential oils are complex mixtures of volatile plant extracts. Each essential oil has a unique chemical composition that determines its distinctive aroma and potential therapeutic effects [1]. Thyme essential oil, obtained from the fresh or dried leaves and flowers of Thymus spp. through steam distillation, is widely used in industries such as medicine, pharmacy, perfumery-cosmetics and food [2]. Additionally, it exhibits a variety of biological properties such as antimicrobial activity, antitussive, antispasmodic and antioxidative [3]. Ensuring the quality and safety of essential oils is of great importance for public health due to potential deviations from the established standards pose a risk to consumers. This study aimed to evaluate the quality of 12 different Thyme essential oil samples from pharmacies and non-pharmacy markets (various sources) via focusing on their adherence to the standards set by the European Pharmacopoeia (EP). The EP serves as the official reference for national and international regulations, providing both qualitative and quantitative methods for analyzing active ingredients and excipients used in pharmaceutical production. Initially, appearance, solubility and resinified essential oils tests were done to primarily evaluate possible adulterations. Then, High-Performance Thin Layer Chromatography (HPTLC) and Gas Chromatography-Mass Spectrometry (GC-MS) techniques were applied to all Thyme essential oil samples to provide comprehensive information about their phytochemical composition. Additionaly, relative density and refractive index tests were employed for each sample. Results revealed that none of the samples on the Turkish market meet the standarts of EP 10.0 criteria. The proportion of samples meeting the criteria is 43.75% for those sourced from pharmacies, compared to 39.38% for non-pharmacy samples. The inability of the Thyme essential oil samples to meet the EP standards highlights the need for greater efforts and regulatory oversight to enhance the quality of products available in the market.